| Basics |
Laboratory Corporation of America Holdings
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.
|
| IPO Date: |
May 9, 1995 |
| Sector: |
Healthcare |
| Industry: |
Health Care Providers and Services |
| Market Cap: |
$21.42B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.21 | 0.89%
|
| Avg Daily Range (30 D): |
$3.14 | 1.20%
|
| Avg Daily Range (90 D): |
$2.51 | 0.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.8M |
| Avg Daily Volume (30 D): |
.85M |
| Avg Daily Volume (90 D): |
.53M |
| Trade Size |
| Avg Trade Size (Sh.): |
91 |
| Avg Trade Size (Sh.) (30 D): |
31 |
| Avg Trade Size (Sh.) (90 D): |
30 |
| Institutional Trades |
| Total Inst.Trades: |
19,340 |
| Avg Inst. Trade: |
$5.18M |
| Avg Inst. Trade (30 D): |
$21.53M |
| Avg Inst. Trade (90 D): |
$19.02M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$12.63M |
| Avg Closing Trade (30 D): |
$42.09M |
| Avg Closing Trade (90 D): |
$31.41M |
| Avg Closing Volume: |
71.53K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$10.26
|
$3.14
|
$2.85
|
|
Diluted EPS
|
$10.19
|
$3.12
|
$2.84
|
|
Revenue
|
$ 13.77B
|
$ 3.56B
|
$ 3.53B
|
|
Gross Profit
|
$ 3.92B
|
$ 1.03B
|
$ 1.05B
|
|
Net Income / Loss
|
$ 856.4M
|
$ 261.5M
|
$ 238.3M
|
|
Operating Income / Loss
|
$ 1.33B
|
$ 396.6M
|
$ 394.5M
|
|
Cost of Revenue
|
$ 9.85B
|
$ 2.54B
|
$ 2.48B
|
|
Net Cash Flow
|
$ -940.5M
|
$ -46.3M
|
$ 259.1M
|
|
PE Ratio
|
25.43
|
|
|
| Splits |
|
Jul 03, 2023:
1164:1000
|
|
May 13, 2002:
2:1
|
|
Jun 12, 2001:
2:1
|
|
May 04, 2000:
1:10
|
|
|
|
